Skip to content

Effect of transcranial electrical stimulation on cognitive and motor function

The efficacy of transcranial electrical stimulation in improving cognitive and motor dysfunction in patients with post-stroke depression or insomnia

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300074898
Enrollment
Unknown
Registered
2023-08-18
Start date
2023-08-20
Completion date
Unknown
Last updated
2024-04-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

stroke

Interventions

Test group:transcranial electrical stimulation
Control group:sham stimulation

Sponsors

The Third Affiliated Hospital of Sun Yat-sen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
35 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. First stroke; 2. The lesions located in the cerebral hemisphere cortex and subcortical; 3. The course of disease was between 2 weeks and 3 months; 4. Hamilton Depression Scale (HAMD) score > 8 points; 5. Pittsburgh Sleep Quality Index (PSQI) >= 8 or subjective sleep difficulty; 6. Mild to moderate cognitive impairment (10 <= MMSE < 26 points); 7. Aged 35-75 years; 8. Stable vital signs without progressive neurological symptoms; 9. If cognitive-improving or antidepressant drugs were used, no dose adjustment was made within 1 week; 10. Voluntary participation and signed informed consent.

Exclusion criteria

Exclusion criteria: 1. Previous history of brain tumor, traumatic brain injury, epilepsy or mental disorder; 2. After craniotomy/skull defect; 3. Metal or electronic device implants (such as cardiac pacemakers, cochlear implants, deep brain stimulators, aneurysm clips, internal fixation devices after ventriculoperitoneal shunt, etc.); 4. Impaired skin integrity at the electrode placement site, or allergy to electrode gel or adhesive; 5. Severe aphasia, visual and hearing impairment, able to complete the study protocol; 6. Unstable heart disease, hypertension, and other serious medical conditions that may affect the study.

Design outcomes

Primary

MeasureTime frame
Montreal Cognitive Assessment;function connectivity;

Secondary

MeasureTime frame
Digit Span Test;Fugl-Meyer Assessment;Hamilton Depression Scale;Pittsburgh Sleep Quality Index;Modified Barthel Index; accuracy of GONOGO;Amplitude and latency of event-related potentials;

Countries

China

Contacts

Public ContactXiquan Hu

The Third Affiliated Hospital of Sun Yat-sen University

huxiquan@mail.sysu.edu.cn+86 189 2210 2910

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jul 23, 2026